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Introduction
Predominant form of childhood sclerosis is localized
scleroderma (LSc) or morphoea. Preliminary classifica-
tion includes circumscribed morphoea (CM), linear
scleroderma (LS), generalized (GM), panclerotic (PM)
and mixed morphoea (MM). The major problem in
untreated patients is morbidity, so the aim of the ther-
apy is to prevent this.
Methods
We report data on clinical, laboratory and treatment
features in a descriptive observational study of 44 chil-
dren with LSc assisted at our hospital from January
2000 to November 2010.
Results
70.5% of patients were females. CM (34.1%) and LM
(34.1%) were the most frequently subtypes. Mean age at
first symptoms was 7.7 years (Figure 1). Medium time
between first signs/symptoms and diagnosis was 15.42
months. One patient with CM head-neck lesions had
Parry-Romberg disease with neurological involvement.
50% of patients with head-neck LM had “coup de sabre”
subtype, 25% of that with neurological involvement. One
patient had joint movement limitation and another limb
dysmetria. 38.6% patients tested positive for ANA, none
developed SLE. Scl-70 and anticentromere were negative
in all. Drugs most frequently used were topical corticos-
teroids (61.3%), methotrexate and systemic corticoster-
oids (38.6%) and topical tacrolimus (36.4%). Time to
remission was 6.95 months. 34.09% of patients had clini-
cal relapse, 26.6% of these being on treatment.
Conclusions
1.- Long time to diagnosis shows the poor recognition
of clinical features of LSc and makes difficult an early
treatment to prevent disabilities.
2.- Neurological involvement in patients with lesions
on head and neck suggests the importance of an exhaus-
tive neurological examination in these patients.
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Figure 1 Main demographic features. Abbreviations: circumscribed
morphoea (CM), linear scleroderma (LS), generalized (GM),
panclerotic (PM) and mixed morphoea (MM).
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